| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $977.1M | -24.1% |
| Cost of Revenue | $639.0M | -14.3% |
| Gross Profit | $338.2M | -37.6% |
| R&D Expense | $109.8M | +11.2% |
| SG&A Expense | $124.3M | -1.1% |
| Operating Income | -$208.3M | -189.8% |
| Pre-tax Income | -$161.9M | -158.9% |
| Income Tax | $19.6M | -64.9% |
| Net Income | -$181.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $620.0M | +20.5% |
| Short-term Investments | $310.2M | -53.2% |
| Accounts Receivable | $171.1M | -21.9% |
| Inventory | $284.8M | -37.3% |
| Current Assets | $1.43B | -25.3% |
| Total Assets | $2.29B | -15.2% |
| Current Liabilities | $205.0M | -4.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $247.9M | -16.2% |
| Capital Expenditures | $98.5M | -10.8% |
| Investing Cash Flow | $208.7M | +187.9% |
| Financing Cash Flow | -$339.6M | -43.7% |
| Free Cash Flow | $149.4M | -19.5% |
| -182.9% |
| EPS (Basic) | -$4.09 | -188.1% |
| EPS (Diluted) | -$4.09 | -188.3% |
| Total Liabilities |
| $264.8M |
| -6.6% |
| Stockholders' Equity | $2.02B | -16.2% |